Skip to main content
Log in

An animal model of calcium oxalate urolithiasis based on a cyclooxygenase 2 selective inhibitor

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstracts

Our aim was to develop a stone-forming animal model involving renal tubular injury using a cyclooxygenase 2 selective inhibitor. Male Sprague-Dawley rats fed chow containing 3% sodium oxalate with or without 100 mg/kg celecoxib were compared to animals fed normal chow. Rats were killed after 2 or 4 weeks and the kidneys were harvested for morphological examination. Collections of 24-h urine were made before kidney harvest. After 2 weeks only a few crystals were observed in rats that received oxalate and celecoxib, but after 4 weeks more crystals were observed at the renal papilla than in rats that received only oxalate. Few crystals were found in rats fed normal chow with or without celecoxib. The urinary activities of gamma-glutamyl transpeptidase (GGT) were increased by celecoxib administration whereas creatinine clearance rates were unchanged. In rats fed oxalate, urinary oxalate excretion increased, but calcium excretion decreased. This model using a cyclooxygenase 2 selective inhibitor is a useful stone forming animal model involving mild renal tubular injury together with mild hyperoxaluria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kahn SR, Hackett RL (1985) Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature. Scanning Elect Microsc 1985: 759

    Google Scholar 

  2. Kumar S, Sigmon D, Carpenter B, Khan S, Scheid C, Menon M et al. (1991) A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 146: 1384

    PubMed  Google Scholar 

  3. Kwak C, Kim HK, Kim EC, Choi MS, Kim HH (2003) Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 44: 475

    Article  PubMed  Google Scholar 

  4. Kleinschmidt K, Mahlmann A, Hautmann R (1993) Anaerobic oxalate-degrading bacteria in the gut decrease faecal and urinary oxalate concentrations in stone formers. In: Ryall R, Basis R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis 2. Plenum, New York, p 439

  5. Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, De Simone C et al. (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60: 1097

    Article  PubMed  Google Scholar 

  6. Kajander EO, Ciftcioglu N (1998) Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A 95: 8274

    Article  PubMed  Google Scholar 

  7. Szasz G (1969) A kinetic photometric method for serum gamma-glutamyl transpeptidase. Clin Chem Acta 15: 124

    Google Scholar 

  8. Stirling JL (1969) Beta galactosidase, beta-glucosidase and N-acetyl-beta-glucosaminidase in human kidney. Clin Chim Acta 24: 189

    Article  PubMed  Google Scholar 

  9. Chiriboga J (1966) Purification and properties of oxalic acid oxidase. Arch Biochem Biophys 116: 516

    Article  PubMed  Google Scholar 

  10. Toftegoarrd NT (1976) A method for enzymatic determination of citrate in serum and urine. Scand J Clin Lab Invest 36: 513

    PubMed  Google Scholar 

  11. Cohen SA, Sideman L (1979) Modification of the o-cresolphthalein complexone method for determining calcium. Clin Chem 25: 1519

    PubMed  Google Scholar 

  12. Jaffe M (1886) Uber den Niederschlag, welchen Picrinsaure in normalen Harn erzeugt und über eine neue Reaction des Keratinins. Hoppe Zeylersz Physiol Chem 10: 391

    Google Scholar 

  13. Lyon ES, Borden TA, Vermeulen CW (1966) Experimental oxalate lithiasis produced with ethylene glycol. Invest Urol 4: 143

    PubMed  Google Scholar 

  14. McIntosh GH, Belling GB, Bulman FH (1979) Experimental oxalate urolith formation in rats. Aust J Exp Biol Med Sci 57: 251

    PubMed  Google Scholar 

  15. Randall A (1940) The etiology of primary renal calculus. Int Abs Surg 71: 209

    Google Scholar 

  16. Gill WB, Ruggiero K, Straus FH (1979) Crystallization studies in an urothelial-lined living test tube (the catheterized female rat bladder). I. Calcium oxalate crystal adhesion to the chemically injured rat bladder. Invest Urol 17: 257

    PubMed  Google Scholar 

  17. Khan SR, Cockrell CA, Finlayson B et al. (1984) Crystal retention by injured urothelium of the rat urinary bladder. J Urol 132: 153

    PubMed  Google Scholar 

  18. Khan SR, Finlayson B, Hackett RL (1982) Experimental calcium oxalate nephrolithiasis in the rat. Role of the renal papilla. Am J Pathol 107: 59

    PubMed  Google Scholar 

  19. Tessitore N, Ortalda V, Fabris A et al. (1985) Renal acidification defects in patients with recurrent calcium nephrolithiasis. Nephron 41: 325

    PubMed  Google Scholar 

  20. Sutton RA, Walker VR (1980) Responses to hydrochlorothiazide and acetazolamide in patients with calcium stones. Evidence suggesting a defect in renal tubular function. N Engl J Med 302: 709

    PubMed  Google Scholar 

  21. Lee JB, Crowshaw K, Takman BH, Attrep KA (1967) The identification of prostag-landins E2, F2a and A2 from rabbit kidney medulla. Biochem J 105: 1251

    Google Scholar 

  22. Daniels EG, Hinman JW, Leach BE, Muirhead EE (1967) Identification of prostaglandin E2 as the principal vasodepressor lipid of rabbit renal medulla. Nature 215: 1298

    PubMed  Google Scholar 

  23. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232

    Google Scholar 

  24. Dunn MD, Hood VL (1977) Prostaglandins and the kidney: an editorial review. Am J Physiol 233: 169

    PubMed  Google Scholar 

  25. Herschman HR (1996) Prostaglandin synthase 2. Biochim Biophys Acta 1299: 125

    PubMed  Google Scholar 

  26. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van de Putte LB, Lipsky PE (1998) Cyclooxygenase in biology and disease. FASEB J 12: 1063

    PubMed  Google Scholar 

  27. Laudanno OM, Cesolari JA, Esnarriaga J, Rista L, Piombo G, Rocaspana A (2001) Gastrointestinal damage induced by celecoxib and rofecoxib in rats. Dig Dis Sci 46: 779

    Article  PubMed  Google Scholar 

  28. Chahwala SB, Harpur ES (1983) Gentamicin-induced hypercalciuria in the rat. Acta Pharmacol Toxicol 53: 358

    Google Scholar 

  29. Farell G, Huang E, Kim SY, Horstkorte R, Lieske JC (2004) Modulation of proliferating renal epithelial cell affinity for calcium oxalate monohydrate crystals. J Am Soc Nephrol 15: 3052

    Article  PubMed  Google Scholar 

  30. Bosomworth MP, Aparicio SR, Hay AW (1999) Urine N-acetyl-{beta}-D-glucosaminidase—a marker of tubular damage? Nephrol Dial Transplant 14: 620

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jung-In Kim or Hyeon Hoe Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeong, B.C., Park, M.Y., Kwak, C. et al. An animal model of calcium oxalate urolithiasis based on a cyclooxygenase 2 selective inhibitor. Urol Res 33, 453–459 (2005). https://doi.org/10.1007/s00240-005-0507-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-005-0507-1

Keywords

Navigation